Point72 Asset Management’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4M | Buy |
1,230,377
+837,889
| +213% | +$36.4M | 0.1% | 221 |
|
|
2025
Q1 | $14.7M | Buy |
392,488
+89,753
| +30% | +$3.35M | 0.03% | 444 |
|
|
2024
Q4 | $13.7M | Sell |
302,735
-404,533
| -57% | -$18.3M | 0.03% | 480 |
|
|
2024
Q3 | $41.5M | Buy |
707,268
+438,036
| +163% | +$25.7M | 0.11% | 210 |
|
|
2024
Q2 | $10.6M | Sell |
269,232
-217,968
| -45% | -$8.58M | 0.03% | 485 |
|
|
2024
Q1 | $32.4M | Sell |
487,200
-221,200
| -31% | -$14.7M | 0.08% | 285 |
|
|
2023
Q4 | $19.8M | Buy |
708,400
+335,292
| +90% | +$9.37M | 0.05% | 376 |
|
|
2023
Q3 | $7.95M | Buy |
+373,108
| New | +$7.95M | 0.02% | 615 |
|